A case of progressive multifocal leucoencephalopathy and cerebral toxoplasmosis in an HIV-infected patient
DOI:
https://doi.org/10.2478/AMB-2023-0032Keywords:
cerebral toxoplasmosis, progressive multifocal leukoencephalopathy, AIDS, immune defi ciency, survivalAbstract
Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection of the central nervous system (CNS) caused by the reactivation of John Cunningham polyomavirus (JCV). Most often, this disease is observed in patients with severe immune suppression, such as those with AIDS. Cerebral toxoplasmosis results from the reactivation of a latent infection with Toxoplasma gondii, an intracellular parasite. This parasitosis is relatively rare in the United States, while in some regions of Europe the seropositive population is over 90%. Similarly, to PML, cerebral toxoplasmosis develops in stages of advanced immune defi ciency. Both of these opportunistic infections of the central nervous system can cause severe neurological symptoms, and their simultaneous presentation can represent a diagnostic and therapeutic problem. We present a case of a 59-year-old patient with a newly diagnosed HIV infection with manifestations of epilepsy and progressive cognitive impairment. The patient was diagnosed initially with cerebral toxoplasmosis and subsequently with progressive multifocal leukoencephalopathy.
References
Albrecht H, Hoff mann C, Degen O, et al. HAART signifi cantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998, 12:1149-1154.
Antinori A, Ammassari A, Giancola ML, et al. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era. J Neurovirol 2001, 7:323-8.
Berenguer J, Miralles P, Arrizabalaga J, et al. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis 2003, 36: 1047-52.
Garcia De Viedma D, Diaz Infantes M, et al. JC virus load in progressive multifocal leukoencephalopathy: analysis of the correlation between the viral burden in cerebrospinal fl uid, patient survival, and the volume of neurological lesions. Clin Infect Dis 2002, 34:1568-75.
Weissert R. Progressive multifocal leukoencephalopathy. J Neuroimmunol. 2011 Feb;231(1-2):73-7. doi: 10.1016/j.jneuroim. 2010.09.021.
Saji AM, Gupta V. Progressive Multifocal Leukoencephalopathy. 2022 Jul 11. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
Abgrall S, Rabaud C, Costagliola D. Incidence and risk factors for toxoplasmic encephalitis in HIV infected patients before and during the HAART era. Clin Infect Dis 2001, 33: 1747-55.
Ayoade F, Joel Chandranesan AS. HIV-1 Associated Toxoplasmosis. 2022 Sep 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan.
Tachikawa N, Goto M, Hoshino Y, et al. Detection of Toxoplasma gondii, Epstein-Barr virus, and JC virus DNAs in the cerebrospinal fl uid in acquired immunodefi ciency syndrome patients with focal central nervous system complications. Intern Med. 1999 Jul;38(7):556-62.
Gheuens S, Cheeseman SH, Koralnik IJ. Hidden in plain view: emergence of progressive multifocal leukoencephalopathy after treatment of CNS toxoplasmosis. Acta Neurol Belg. 2011 Sep;111(3):217-9.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.